Monopar Therapeutics is recovering a drug from the scrap heap of AstraZeneca’s rare disease pipeline. | Monopar Therapeutics ...

Under the terms of the license agreement, Monopar will pay Alexion an upfront in the form of a cash payment and equity in Monopar. Future payments are based on tiered royalties on net sales and ...

and can occur early or late in the disease course. Rarely, patients exhibit chorea of generalized or localized distribution over one half of the body. [31] Myoclonic or tonic-clonic seizure ...

On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 --CAMBRIDGE, ...

Gaucher's disease, Wilson's disease, pheochromocytoma, afibrinogenemia and ruptured ectopic pregnancy. Conclusions Emergency physicians should be attuned to the fact that rupture of the spleen can ...

Whilst all of that is also true for me, Durham symbolises something far greater – the end point on my road to recovery from a ...

Gemma Biotherapeutics, one of two companies launched by former University of Pennsylvania gene therapy program director Dr.

The Georgia-born musician never knew his grandfather but was inspired to develop a musical program based on the courageous man’s life and career as a journalist during the Civil Rights Movement. Adam ...

Explore the symptoms and causes of knee osteoarthritis, a progressive disease that wears away the cartilage of the knee joint. Learn about lifestyle changes, medication, and surgery to manage this ...

On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 -- CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE ...

“We are particularly excited to share in vivo data from our Wilson’s Disease program, as well as from our universal liver-directed lipid nanoparticle (LNP) platform. Together, these data reinforce our ...